Business Context and Reporting Period
Company: HYPERION DEFI, INC. (HYPD)
Filing Type: Form 10-Q (Unaudited)
Period Ended: March 31, 2026
Business Overview: Hyperion DeFi is a U.S. publicly listed company focused on building a strategic treasury of HYPE, the native token of the Hyperliquid blockchain. The company generates revenue through native staking, liquid staking, and proprietary "HYPE Asset Use Service" (HAUS) agreements. The company is simultaneously winding down its legacy Ophthalmic Technology segment (Optejet), with operations expected to cease in Q2 2026.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $244,271 | $14,720 |
| Net Income (Loss) | $8,840,550 | $(3,483,533) |
| Net Income Available to Common Stockholders | $3,235,511 | $(3,483,533) |
| Diluted EPS | $0.26 | $(1.59) |
| Cash and Cash Equivalents (End of Period) | $7,380,922 | $3,934,966 |
| Total Assets | $70,065,963 | $51,764,256 |
| Total Liabilities | $11,570,999 | $10,703,749 |
| Stockholders' Equity | $58,494,964 | $(9,714,001) |
| Notes Payable (Gross) | $8,962,653 | $8,339,386 |
Note: Q1 2025 equity was in deficit; Q1 2026 equity is positive due to significant unrealized gains on digital assets.
Material Changes vs. Prior Period
- Profitability Turnaround: The company reported a net income of $8.8 million in Q1 2026, a reversal from a net loss of $3.5 million in Q1 2025. This shift is primarily driven by non-cash unrealized gains on digital assets ($11.0 million) and realized gains from digital asset derecognition ($3.6 million).
- Revenue Growth: Revenue increased to $244,271 from $14,720, driven by staking rewards and HAUS agreement fees. The Ophthalmic Technology segment generated zero revenue in Q1 2026.
- Expense Fluctuations: Selling, General, and Administrative (SG&A) expenses rose 88% to $4.5 million due to new executive hires and professional fees related to the digital asset strategy. Conversely, Research and Development (R&D) expenses fell 57% to $0.3 million as the Optejet project winds down.
- Balance Sheet Expansion: Total assets grew by approximately $18.3 million, largely due to an increase in the fair value of HYPE digital assets and the accumulation of digital intangible assets (liquid staking tokens).
Outlook, Risks, and Unusual Items
- Management Commentary: Management expects existing resources to fund operations for the next 12 months. The company plans to continue capital raising via "at-the-market" offerings. Subsequent to the quarter, the company closed a public offering raising approximately $8.7 million in net proceeds (May 2026).
- Unusual Items:
- Unrealized Gains: Net income is heavily influenced by $11.0 million in unrealized gains on HYPE digital assets and $0.4 million on digital intangible assets receivable.
- Impairment Losses: The company recorded a $1.2 million impairment loss on digital intangible assets.
- Preferred Stock Dividends: $815,297 in dividends were paid to Series A Preferred Stockholders, reducing net income available to common shareholders.
- Risks and Contingencies:
- USDH Stablecoin Termination: Native Markets announced the cessation of support for the USDH stablecoin (May 2026). The company holds assets referencing USDH (approx. $34 million total exposure including receivables and HAUS agreements) and intends to convert to USDC or cash.
- Material Weakness in Internal Controls: The company identified a material weakness regarding controls over digital asset pricing and principal market determination. Remediation steps are underway.
- Liquidity Constraints: A significant portion of HYPE holdings are staked or locked in HAUS agreements, subject to unstaking queues (7 days) or contractual restrictions (up to 90 days), limiting immediate liquidity.
Investor Verification Checklist
- Asset Valuation: Verify the fair value methodology for HYPE tokens and the impact of the USDH stablecoin termination on the $34 million of USDH-referenced assets.
- Liquidity Position: Assess the company's ability to meet debt obligations ($1.5 million current notes payable) given that a large portion of treasury assets are locked in staking or HAUS agreements.
- Internal Controls: Monitor the remediation progress of the material weakness in digital asset pricing controls.
- Segment Wind-down: Confirm the timeline and financial impact of the complete wind-down of the Ophthalmic Technology segment in Q2 2026.
- Preferred Stock Dilution: Review the terms of the Series A Preferred Stock, including the $50.8 million liquidation preference and the impact of PIK dividends on common equity.